Vancomycin plus rifampicin for methicillin-resistant Staphylococcus aureus pneumonia benefits only those who have no development of rifampicin resistance during treatment.
作者信息
Tan Che-Kim, Lai Chih-Cheng, Lin Sheng-Hsiang, Hsueh Po-Ren
出版信息
Crit Care Med. 2010 Aug;38(8):1754; author reply 1754-5. doi: 10.1097/CCM.0b013e3181db7d28.